Clinical application of inotropic drugs.
D002301:Cardiac Glycosides / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002395:Catecholamines / Q000627:therapeutic use; D003864:Depression, Chemical; D004070:Digitalis; D004077:Digoxin / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011188:Potassium / Q000378:metabolism; D013268:Stimulation, Chemical; D014970:Xanthines / Q000627:therapeutic use
D002301:Cardiac Glycosides; D002316:Cardiotonic Agents; D002395:Catecholamines; D014970:Xanthines; D004077:Digoxin; D011188:Potassium